Recruiting Rheumatoid Arthritis Studies in Litchfield Park
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC). The study will last up to 3 years. Parti...
ABTECT - Maintenance
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisok...
About Rheumatoid Arthritis Clinical Trials in Litchfield Park
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.
There are currently 3 rheumatoid arthritis clinical trials recruiting participants in Litchfield Park, ARIZONA. These studies are seeking a combined 3,133 participants. Research is being sponsored by Eli Lilly and Company, Abivax S.A., Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Rheumatoid Arthritis Clinical Trials in Litchfield Park — FAQ
Are there rheumatoid arthritis clinical trials in Litchfield Park?
Yes, there are 3 rheumatoid arthritis clinical trials currently recruiting in Litchfield Park, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Litchfield Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Litchfield Park research site will contact you about next steps.
Are clinical trials in Litchfield Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Litchfield Park studies also compensate for your time and travel.
What rheumatoid arthritis treatments are being tested?
The 3 active trials in Litchfield Park are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov